University Hospital of Regensburg

Despite market headwinds, endovascular treatments for acute ischemic stroke (AIS) continue to represent a large, rapidly emerging market with a worldwide opportunity estimated at more than $1 billion.

Despite market headwinds, endovascular treatments for acute ischemic stroke (AIS) continue to represent a large, rapidly emerging market with a worldwide opportunity estimated at more than $1 billion.

Mergers & Acquisitions /In Vitro Diagnostics Clovis Oncology Inc. Roche Roche Diagnostics Roche Molecular Systems Inc. On the same day it received rights to a solid tumor compound from Pfizer Inc.

In Vitro Diagnostics ARCA biopharma Inc. University of Cincinnati ARCA biopharma gets rights to create a companion diagnostic for Gencaro from Univ. of Cincinnati ARCA biopharma Inc. (therapeutics